Search
Coltuximab ravtansine
go.drugbank.com/drugs/DB06342InvestigationalColtuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
Chlorocresol
go.drugbank.com/drugs/DB16864InvestigationalCategories: Compounds used in a research, industrial, or household settingGoralatide
go.drugbank.com/drugs/DB20748ExperimentalGoralatide is a small molecule drug. Goralatide has a monoisotopic molecular weight of 487.23 Da.
Categories: Compounds used in a research, industrial, or household settingIndigo
go.drugbank.com/drugs/DB16862InvestigationalCategories: Compounds used in a research, industrial, or household settingN-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate
go.drugbank.com/drugs/DB02643ExperimentalCategories: Compounds used in a research, industrial, or household settingSynonyms: N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-PropanesulfonateCyromazine
go.drugbank.com/drugs/DB20549ExperimentalCyromazine is a small molecule drug. Cyromazine has a monoisotopic molecular weight of 166.1 Da.
Categories: Compounds used in a research, industrial, or household settingLunacalcipol
go.drugbank.com/drugs/DB05024Investigationalsecretion which may be involved in the etiology of psoriasis. … Preclinical studies have shown that CTA018 inhibits the proliferation of rapidly dividing cells such as human epidermal keratinocytes (skin cells) and is also effective in inhibiting pro-inflammatory cytokine
Citrulline
go.drugbank.com/drugs/DB00155InvestigationalNutraceuticalCitrulline is an amino acid. It is made from ornithine and carbamoyl phosphate in one of the central reactions in the urea cycle.
Synonyms: N(delta)-Carbamylornithine, N(5)-(Aminocarbonyl)-L-ornithineThiacloprid
go.drugbank.com/drugs/DB08620ExperimentalCategories: Compounds used in a research, industrial, or household settingImolamine
go.drugbank.com/drugs/DB09284InvestigationalImolamine is a compound with a molecular weight of 260.33 g/mol with the formula diethyl[2-{5-imino-3-phenyl-4,5-dihydro-1,2,3-oxadiazol,-4-yl)ethyl]amine. It is developed under the brand name Coremax by Novartis consumer health SA.
Categories: Vasodilators Used in Cardiac Diseases